《美国FDA规范饮食补充品标签》

  • 来源专题:食物与营养
  • 编译者: 潘淑春
  • 发布时间:2008-06-20
  • 2008-06-19 国家食品安全网讯:最近,美国FDA(食品和药物管理局)发出通报,要求将草本制品区分为药品和饮食补充品。如属药品,在进入美国市场前必须经FDA批准;如属饮食补充品,进入美国市场前无需向FDA注册或获得其批准,但必须保证产品的安全性和有效性,并符合FDA有关饮食补充品标签的有关规定。
  • 原文来源:http://www.cfs.gov.cn/cmsweb/webportal/W192/A64027827.html
相关报告
  • 《FDA出台食品包装营养标签新法规》

    • 来源专题:食物与营养
    • 编译者:潘淑春
    • 发布时间:2008-03-27
    • 近年来,美国食品和药品管理局(FDA)一直在不断地修订食品包装营养标签方面的法规,以使其更加完善,并符合新的形势要求,最大限度地保证消费者的饮食健康。FDA近日又出台了一项新规定,要求在传统食品和膳食补充品的营养标签中,标注反式脂肪酸(简称“TFAS”)的含量。
  • 《二十多年的膳食补充健康与教育法 — — 膳食补充剂应如何规范?》

    • 来源专题:营养与健康
    • 编译者:xinning
    • 发布时间:2015-08-09
    • The Dietary Supplement Health and Education Act (DSHEA) of 1994 defines the FDA’s statutory authority to regulate dietary supplement products in the United States. The dietary supplement industry has rapidly expanded since 1994, presenting an obvious need for “DSHEA 2.0.” Current regulations surrounding dietary supplements have been increasingly and reasonably scrutinized, given their widespread use by over one-half of the US population as well as highly publicized safety concerns over the past 20 y. As the market continues to expand and evolve, so too must the laws that protect consumers from potential harm and misleading communication. This article is meant to begin a scientific dialogue on how regulations may be improved to provide both ease of access and safer products to the consumer by focusing on 4 topics: premarket approval, label claims, current Good Manufacturing Practices, and adverse event reporting. .